Date published: 2026-4-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

Concanamycin B (CAS 81552-33-2)

0.0(0)
Write a reviewAsk a question

See product citations (2)

Application:
Concanamycin B is an antibiotic and inhibitor of vacuolar-type H+-ATPase
CAS Number:
81552-33-2
Purity:
≥96%
Molecular Weight:
852.1
Molecular Formula:
C45H73NO14
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Concanamycin B, identified by the CAS number 81552-33-2, is a chemical compound closely related to concanamycin A and is also derived from the bacterium Streptomyces neyagawaensis. Like its counterpart, concanamycin B functions as an inhibitor of the vacuolar-type H+-ATPase (V-ATPase), an essential enzyme complex involved in the acidification of intracellular compartments such as lysosomes, endosomes, and the Golgi apparatus. The inhibition of V-ATPase by concanamycin B disrupts the normal acidification process, which is pivotal for a variety of cellular functions including protein degradation, nutrient processing, and the activation of enzymes that require an acidic environment to function. In research, concanamycin B has been utilized to probe the role and regulatory mechanisms of V-ATPases in cellular processes. By inhibiting this enzyme, researchers can study the effects of altered pH levels within cellular organelles on overall cell physiology. This includes investigations into how cells process and recycle their components, how they respond to environmental stressors, and how intracellular trafficking pathways are regulated. The use of concanamycin B in these studies provides crucial insights into the fundamental processes of cellular maintenance and function, contributing to a broader understanding of cellular homeostasis and pathology.


Concanamycin B (CAS 81552-33-2) References

  1. In vivo rapid reduction of alloantigen-activated CD8+ mature cytotoxic T cells by inhibitors of acidification of intracellular organelles, prodigiosin 25-C and concanamycin B.  |  Lee, MH., et al. 2000. Immunology. 99: 243-8. PMID: 10692043
  2. Induction of EGF-dependent apoptosis by vacuolar-type H(+)-ATPase inhibitors in A431 cells overexpressing the EGF receptor.  |  Yoshimoto, Y. and Imoto, M. 2002. Exp Cell Res. 279: 118-27. PMID: 12213220
  3. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus.  |  Fredericksen, BL., et al. 2002. J Virol. 76: 11440-6. PMID: 12388705
  4. Inhibition of the acidification of endosomes and lysosomes by the antibiotic concanamycin B in macrophage J774.  |  Woo, JT., et al. 1992. Eur J Biochem. 207: 383-9. PMID: 1628660
  5. Concanamycin A, a vacuolar type H(+)-ATPase inhibitor, induces cell death in activated CD8(+) CTL.  |  Togashi, K., et al. 1997. Cytotechnology. 25: 127-35. PMID: 22358885
  6. Isolation and characterization of concanamycins A, B and C.  |  Kinashi, H., et al. 1984. J Antibiot (Tokyo). 37: 1333-43. PMID: 6511660
  7. Prodigiosin 25-C suppression of cytotoxic T cells in vitro and in vivo similar to that of concanamycin B, a specific inhibitor of vacuolar type H(+)-ATPase.  |  Lee, MH., et al. 1995. Biosci Biotechnol Biochem. 59: 1417-21. PMID: 7549091
  8. Concanamycin B inhibits the expression of newly-synthesized MHC class II molecules on the cell surface.  |  Ito, K., et al. 1995. J Antibiot (Tokyo). 48: 488-94. PMID: 7622435
  9. Concanamycin B, a vacuolar H(+)-ATPase specific inhibitor suppresses bone resorption in vitro.  |  Woo, JT., et al. 1996. Biol Pharm Bull. 19: 297-9. PMID: 8850326
  10. Characterization of a lysozyme-major histocompatibility complex class II molecule-loading compartment as a specialized recycling endosome in murine B lymphocytes.  |  Escola, JM., et al. 1996. J Biol Chem. 271: 27360-5. PMID: 8910313

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Concanamycin B, 100 µg

sc-221434
100 µg
$463.00

Concanamycin B, 500 µg

sc-221434A
500 µg
$1569.00